ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 118 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | -48.6% | 4,009 | -26.6% | 0.00% | – |
| Q2 2023 | $35 | -58.8% | 5,462 | -51.9% | 0.00% | – |
| Q1 2023 | $85 | -91.6% | 11,347 | -88.7% | 0.00% | -100.0% |
| Q4 2022 | $1,017 | -99.8% | 100,491 | +65.3% | 0.00% | 0.0% |
| Q3 2022 | $601,000 | +128.5% | 60,786 | +145.3% | 0.00% | – |
| Q2 2022 | $263,000 | -47.0% | 24,782 | -51.4% | 0.00% | – |
| Q1 2022 | $496,000 | -59.4% | 50,956 | -40.3% | 0.00% | -100.0% |
| Q4 2021 | $1,221,000 | +110.2% | 85,424 | +202.0% | 0.00% | 0.0% |
| Q3 2021 | $581,000 | -3.3% | 28,282 | +3.5% | 0.00% | 0.0% |
| Q2 2021 | $601,000 | +461.7% | 27,322 | +761.9% | 0.00% | – |
| Q1 2021 | $107,000 | – | 3,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |